RespireRx Pharmaceuticals Inc (RSPI)

[neuroinv]

Just about every deal I can think of comes with redacted detail regarding the timing/conditions/precise amount of milestone payments-and royalty tiering, though the latter does not apply in this case. Partners don't want too much detail about what they have agreed to made public, so that other parties they are dealing with don't treat the details as a precedent to be continued.

NeuroInvestment